Evidence map›Paper›PMID 25383239›Full record

ArticleJournal of genetic syndromes & gene therapy2011

Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A.

Philip M Zakas, H Trent Spencer, Christopher B Doering

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of genetic syndromes & gene therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. HDAd5/35Molecular therapy. Methods & clinical development · 2018
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philip M ZakasGraduate Program in Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University.
H Trent SpencerAflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Christopher B DoeringAflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.

Funding

Hematopoietic gene therapy for hemophilia AR01HL092179 · NHLBI · EMORY UNIVERSITY · PI DOERING, CHRISTOPHER BRADLEY, SPENCER, H TRENT · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL092179
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25383239
PMCPMC4220243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.